Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Amazon
AMZN
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
RNTX Rein Therapeutics
- 1.820
- +0.060+3.41%
Trading Apr 29 11:32 ET
40.03MMarket Cap-0.52P/E (TTM)
1.820High1.510Low15.31KVolume1.770Open1.760Pre Close25.82KTurnover0.08%Turnover RatioLossP/E (Static)21.99MShares4.40052wk High4.26P/B35.95MFloat Cap1.35052wk Low--Dividend TTM19.75MShs Float309.600Historical High--Div YieldTTM17.61%Amplitude1.010Historical Low1.685Avg Price1Lot Size
About Rein Therapeutics Company
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.
Company Profile
SymbolRNTX
Company NameRein Therapeutics
Listing DateJun 29, 2017
Founded2001
CEODr. James Brian Windsor, PhD
MarketNASDAQ
Employees11
Fiscal Year Ends12-31
Address12407 North Mopac Expressway,Suite 250
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78758
Phone1-737-802-1989
Websitehttp://www.reintx.com
Company Executives
- Name
- Position
- Salary
- Dr. James Brian Windsor, PhD
- Chief Executive Officer, President and Director
- 289.64K
- Timothy M. Cunningham
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Joseph H. Von Rickenbach
- Chairman of the Board
- 67.97K
- Dr. Manuel C. Alves-Aivado, M.D.,PhD
- Director
- 630.74K
- William Carl Fairey, Jr
- Independent Director
- 13.76K
- Alan A. Musso
- Independent Director
- 15.64K
- Dr. Reinhard J. Ambros, PhD
- Independent Director
- 46.25K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now